跳至主要内容
临床试验/NCT04811079
NCT04811079已完成不适用

The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer

Johnson & Johnson Vision Care, Inc.1 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2021年7月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
53
试验地点
1
主要终点
Visual Photosensitivity Threshold (VPT)

研究概览

简要总结

This is a 6-visit, single-center, non-dispensing, randomized, single-masked, 5×5 crossover study. Subjects will participate in 6 scheduled over the duration of approximately 10.5 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Potential subjects must satisfy all of the following criteria to be enrolled in the study:
  • •The subject must read and sign the Informed Consent form.
  • •The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • •Healthy adult males or females age ≥18 and ≤30 years of age.
  • •Normal color vision as measured using the Ishihara 38-plate test.
  • •Normal stereopsis as measured by a suitable test.
  • •Auto-refraction must show a spherical component of -2.00 through +2.00 D, and a cylindrical component of 0.00 through 1.50 D.
  • •The subject's distance refractive sphere must be between -2.00 and +2.00 D in each eye.
  • •The subject's distance refractive cylinder must be ≤ 1.50 D in each eye.
  • •The subject must have unaided distance Snellen visual acuity of 20/200 or better for each eye.
  • •The subject must have best corrected distance Snellen visual acuity of 20/25 or better for each eye.

排除标准

  • •Potential subjects who meet any of the following criteria will be excluded from participating in the study:
  • •Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).
  • •History of refractive surgery or other ocular surgery.
  • •Employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).
  • •Subjects that participated in the pilot study CR-
  • •Systemic conditions or the use of medications that the investigator believes will contraindicate participation in this study.
  • •Abnormal Level 3 neuro-ophthalmology exam including crystalline lens clarity Grade 3 or worse (Lens Opacities Classification System).
  • •Any Grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA Slit Lamp Classification Scale.

研究组 & 干预措施

Spectacle Filter Sequence 4

Experimental

(476nm, 373nm, 456nm, 419nm, 437nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 4.

干预措施: 476 nm Spectacle Filter (Other)

Spectacle Filter Sequence 4

Experimental

(476nm, 373nm, 456nm, 419nm, 437nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 4.

干预措施: 373 nm Spectacle Filter (Other)

Spectacle Filter Sequence 5

Experimental

(373nm, 419nm, 476nm, 437nm, 456nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 5.

干预措施: 419 nm Spectacle Filter (Other)

Spectacle Filter Sequence 8

Experimental

(419nm, 373nm, 437nm, 476nm, 456nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 8.

干预措施: 456 nm Spectacle Filter (Other)

Spectacle Filter Sequence 8

Experimental

(419nm, 373nm, 437nm, 476nm, 456nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 8.

干预措施: 476 nm Spectacle Filter (Other)

Spectacle Filter Sequence 8

Experimental

(419nm, 373nm, 437nm, 476nm, 456nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 8.

干预措施: 373 nm Spectacle Filter (Other)

Spectacle Filter Sequence 1

Experimental

(419nm, 437nm, 373nm, 456nm, 476nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 1.

干预措施: 419 nm Spectacle Filter (Other)

Spectacle Filter Sequence 1

Experimental

(419nm, 437nm, 373nm, 456nm, 476nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 1.

干预措施: 437 nm Spectacle Filter (Other)

Spectacle Filter Sequence 1

Experimental

(419nm, 437nm, 373nm, 456nm, 476nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 1.

干预措施: 456 nm Spectacle Filter (Other)

Spectacle Filter Sequence 3

Experimental

(456nm, 476nm, 437nm, 373nm, 419nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 3.

干预措施: 373 nm Spectacle Filter (Other)

Spectacle Filter Sequence 4

Experimental

(476nm, 373nm, 456nm, 419nm, 437nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 4.

干预措施: 419 nm Spectacle Filter (Other)

Spectacle Filter Sequence 4

Experimental

(476nm, 373nm, 456nm, 419nm, 437nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 4.

干预措施: 437 nm Spectacle Filter (Other)

Spectacle Filter Sequence 4

Experimental

(476nm, 373nm, 456nm, 419nm, 437nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 4.

干预措施: 456 nm Spectacle Filter (Other)

Spectacle Filter Sequence 1

Experimental

(419nm, 437nm, 373nm, 456nm, 476nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 1.

干预措施: 476 nm Spectacle Filter (Other)

Spectacle Filter Sequence 1

Experimental

(419nm, 437nm, 373nm, 456nm, 476nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 1.

干预措施: 373 nm Spectacle Filter (Other)

Spectacle Filter Sequence 2

Experimental

(437nm, 456nm, 419nm, 476nm, 373nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 2.

干预措施: 419 nm Spectacle Filter (Other)

Spectacle Filter Sequence 2

Experimental

(437nm, 456nm, 419nm, 476nm, 373nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 2.

干预措施: 437 nm Spectacle Filter (Other)

Spectacle Filter Sequence 2

Experimental

(437nm, 456nm, 419nm, 476nm, 373nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 2.

干预措施: 456 nm Spectacle Filter (Other)

Spectacle Filter Sequence 2

Experimental

(437nm, 456nm, 419nm, 476nm, 373nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 2.

干预措施: 476 nm Spectacle Filter (Other)

Spectacle Filter Sequence 2

Experimental

(437nm, 456nm, 419nm, 476nm, 373nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 2.

干预措施: 373 nm Spectacle Filter (Other)

Spectacle Filter Sequence 3

Experimental

(456nm, 476nm, 437nm, 373nm, 419nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 3.

干预措施: 419 nm Spectacle Filter (Other)

Spectacle Filter Sequence 3

Experimental

(456nm, 476nm, 437nm, 373nm, 419nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 3.

干预措施: 437 nm Spectacle Filter (Other)

Spectacle Filter Sequence 3

Experimental

(456nm, 476nm, 437nm, 373nm, 419nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 3.

干预措施: 456 nm Spectacle Filter (Other)

Spectacle Filter Sequence 3

Experimental

(456nm, 476nm, 437nm, 373nm, 419nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 3.

干预措施: 476 nm Spectacle Filter (Other)

Spectacle Filter Sequence 5

Experimental

(373nm, 419nm, 476nm, 437nm, 456nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 5.

干预措施: 437 nm Spectacle Filter (Other)

Spectacle Filter Sequence 5

Experimental

(373nm, 419nm, 476nm, 437nm, 456nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 5.

干预措施: 456 nm Spectacle Filter (Other)

Spectacle Filter Sequence 5

Experimental

(373nm, 419nm, 476nm, 437nm, 456nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 5.

干预措施: 476 nm Spectacle Filter (Other)

Spectacle Filter Sequence 5

Experimental

(373nm, 419nm, 476nm, 437nm, 456nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 5.

干预措施: 373 nm Spectacle Filter (Other)

Spectacle Filter Sequence 6

Experimental

(476nm, 456nm, 373nm, 437nm, 419nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 6.

干预措施: 419 nm Spectacle Filter (Other)

Spectacle Filter Sequence 6

Experimental

(476nm, 456nm, 373nm, 437nm, 419nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 6.

干预措施: 437 nm Spectacle Filter (Other)

Spectacle Filter Sequence 6

Experimental

(476nm, 456nm, 373nm, 437nm, 419nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 6.

干预措施: 456 nm Spectacle Filter (Other)

Spectacle Filter Sequence 6

Experimental

(476nm, 456nm, 373nm, 437nm, 419nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 6.

干预措施: 476 nm Spectacle Filter (Other)

Spectacle Filter Sequence 6

Experimental

(476nm, 456nm, 373nm, 437nm, 419nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 6.

干预措施: 373 nm Spectacle Filter (Other)

Spectacle Filter Sequence 7

Experimental

(373nm, 476nm, 419nm, 456nm, 437nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 7.

干预措施: 419 nm Spectacle Filter (Other)

Spectacle Filter Sequence 7

Experimental

(373nm, 476nm, 419nm, 456nm, 437nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 7.

干预措施: 437 nm Spectacle Filter (Other)

Spectacle Filter Sequence 7

Experimental

(373nm, 476nm, 419nm, 456nm, 437nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 7.

干预措施: 456 nm Spectacle Filter (Other)

Spectacle Filter Sequence 7

Experimental

(373nm, 476nm, 419nm, 456nm, 437nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 7.

干预措施: 476 nm Spectacle Filter (Other)

Spectacle Filter Sequence 7

Experimental

(373nm, 476nm, 419nm, 456nm, 437nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 7.

干预措施: 373 nm Spectacle Filter (Other)

Spectacle Filter Sequence 8

Experimental

(419nm, 373nm, 437nm, 476nm, 456nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 8.

干预措施: 419 nm Spectacle Filter (Other)

Spectacle Filter Sequence 8

Experimental

(419nm, 373nm, 437nm, 476nm, 456nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 8.

干预措施: 437 nm Spectacle Filter (Other)

Spectacle Filter Sequence 9

Experimental

(437nm, 419nm, 456nm, 373nm, 476nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 9.

干预措施: 419 nm Spectacle Filter (Other)

Spectacle Filter Sequence 9

Experimental

(437nm, 419nm, 456nm, 373nm, 476nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 9.

干预措施: 437 nm Spectacle Filter (Other)

Spectacle Filter Sequence 9

Experimental

(437nm, 419nm, 456nm, 373nm, 476nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 9.

干预措施: 456 nm Spectacle Filter (Other)

Spectacle Filter Sequence 9

Experimental

(437nm, 419nm, 456nm, 373nm, 476nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 9.

干预措施: 476 nm Spectacle Filter (Other)

Spectacle Filter Sequence 9

Experimental

(437nm, 419nm, 456nm, 373nm, 476nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 9.

干预措施: 373 nm Spectacle Filter (Other)

Spectacle Filter Sequence 10

Experimental

(456nm, 437nm, 476nm, 419nm, 373nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 10.

干预措施: 419 nm Spectacle Filter (Other)

Spectacle Filter Sequence 10

Experimental

(456nm, 437nm, 476nm, 419nm, 373nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 10.

干预措施: 437 nm Spectacle Filter (Other)

Spectacle Filter Sequence 10

Experimental

(456nm, 437nm, 476nm, 419nm, 373nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 10.

干预措施: 456 nm Spectacle Filter (Other)

Spectacle Filter Sequence 10

Experimental

(456nm, 437nm, 476nm, 419nm, 373nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 10.

干预措施: 476 nm Spectacle Filter (Other)

Spectacle Filter Sequence 10

Experimental

(456nm, 437nm, 476nm, 419nm, 373nm) Eligible subjects will be enrolled in Spectacle Filter Sequence 10.

干预措施: 373 nm Spectacle Filter (Other)

结局指标

主要结局

Visual Photosensitivity Threshold (VPT)

时间窗: at approximately 2-week follow-up

VPT will measured via the SAOPA instrument. VPT is the point at which a sensation of pain or discomfort occurs when the intensity of light is gradually increased from a low level. Subject's discomfort responses will be indicated via a button press. Testing is complete when 10 response reversals are acquired.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验